2015 – Biz News Today

Seattle Genetics and Bristol-Myers Squibb Announce Initiation of Phase 1/2 Clinical Trial of ADCETRIS® (Brentuximab Vedotin) in Combination with Opdivo® (Nivolumab) in Relapsed or Refractory Non-Hodgkin Lymphoma

On December 23, 2015

Business News

Original Source

Bristol-Myers Squibb to Sell its HIV R&D Portfolio to ViiV Healthcare

On December 18, 2015

Business News

Original Source

BMS and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Enter Into a Collaboration Agreement as Part of U.S. Immuno-Oncology Rare Population Malignancy Program

On December 17, 2015

Business News

Original Source

Norwegian Cruise Line Reveals North America, Bahamas and Bermuda Summer 2017 Itineraries

On December 15, 2015

Business News

Norwegian Cruise Line today announced its Summer 2017 deployment, featuringRead More

Norwegian Cruise Line Honored Once Again As "World’s Leading Large Ship Cruise Line" By The World Travel Awards

On December 14, 2015

Business News

Norwegian Cruise Line has once again been named the “World’sRead More

Bristol-Myers Squibb and UCLA Enter into a Collaboration Agreement as Part of U.S. Immuno-Oncology Rare Population Malignancy Research Program

On December 14, 2015

Business News

Original Source

Bristol-Myers Squibb to Announce Results for Fourth Quarter, Full Year 2015 on January 28

On December 11, 2015

Business News

Original Source

AMPLIFY Post-Hoc Early Time Course Analysis Evaluated Recurrent Venous Thromboembolism (VTE), VTE-Related Death and Major Bleeding in Deep Vein Thrombosis and Pulmonary Embolism Patients Treated with Eliquis (apixaban) or Conventional Therapy

On December 10, 2015

Business News

Original Source

Bristol-Myers Squibb Completes Previously Announced Acquisition of Cardioxyl Pharmaceuticals, Inc.

On December 8, 2015

Business News

Original Source

Bristol-Myers Squibb Establishes Center for Molecular Synthesis in New Collaboration with Princeton University

On December 8, 2015

Business News

Original Source

Bristol-Myers Squibb Announces Dividend Increase

On December 8, 2015

Business News

Original Source

New Longer-Term Data for Empliciti (elotuzumab) Showed a Continued Progression-Free Survival Benefit in Patients with Relapsed or Refractory Multiple Myeloma

On December 5, 2015

Business News

Original Source

Bristol-Myers Squibb Receives Multiple Myeloma Research Foundation’s 2015 Collaborator Award

On December 4, 2015

Business News

Original Source

Bristol-Myers Squibb Foundation Marks World AIDS Day with Grants Totaling More than $3.5M for HIV and Cervical and Breast Cancer Programs in Africa

On December 1, 2015

Business News

Original Source

Bristol-Myers Squibb and AbbVie Receive FDA Approval of Empliciti™ (elotuzumab) for the Treatment of Patients with Multiple Myeloma Who Have Received One to Three Prior Therapies

On November 30, 2015

Business News

Original Source

Bristol-Myers Squibb to Present New Data across Multiple Blood Cancers at the 57th Annual Meeting & Exposition of the American Society of Hematology

On November 30, 2015

Business News

Original Source

Bristol-Myers Squibb Announces Regulatory Update for Opdivo (nivolumab) in Advanced Melanoma

On November 27, 2015

Business News

Original Source

European Commission Approves Reconciliation of Indications for nivolumab Under the Opdivo® European Marketing Authorization Application

On November 24, 2015

Business News

Original Source

Bristol-Myers Squibb Announces U.S. Food and Drug Administration Approval for Opdivo (nivolumab) as a Single Agent for the Treatment of Patients with Previously Untreated BRAF Wild-Type Advanced Melanoma

On November 24, 2015

Business News

Original Source

Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab), the Only Treatment to Deliver Significant Overall Survival in Advanced Renal Cell Carcinoma vs. a Standard of Care, in Patients Who Have Received Prior Anti-Angiogenic Therapy1

On November 23, 2015

Business News

Original Source

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/biznews/public_html/wp-includes/functions.php on line 5219